Research Site

Shanghai, Shanghai Municipality 430030

4 studies enrolling now · 9 studies all time

What they study most

ATTR, ATTR-CM, ATTR-Mixed, ATTRv-PN, Asthma, COPD, Chronic Obstructive Pulmonary Disease, Diabetes, Hyperlipidemia, Mixed Dyslipidemia, Inherited Retinal Diseases Caused by RPE65 Mutations, Leber Congenital Amaurosis, Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration, Metastatic Colorectal Cancer

Studies at this site

• Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis — Recruiting now
• JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation — Recruiting now
• A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors — Recruiting now
• Safety and Efficacy Trial of HG004 for Leber Congenital Amaurosis Related to Rpe65 Gene Mutations (STAR) — Recruiting now
• Observational Study of Obstructive Lung Disease (NOVELTY) — Completed
• ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer — Completed
• Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia — Completed
• Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable CAD in Post MI Patients — Stopped early
• A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases — Completed